UTMD
Utah Medical Products, Inc. NASDAQ$64.65
After hrs
$64.86
+0.00%
Mkt Cap $205.9M
52w Low $51.80
64.2% of range
52w High $71.81
50d MA $65.61
200d MA $60.89
P/E (TTM)
19.3x
EV/EBITDA
5.8x
P/B
1.8x
Debt/Equity
0.0x
ROE
2.1%
P/FCF
12.9x
RSI (14)
—
ATR (14)
—
Beta
0.35
50d MA
$65.61
200d MA
$60.89
Avg Volume
14.8K
About
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peri…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | BMO | — | 0.82 | — | 69.63 | +0.5% | -2.5% | -3.5% | -4.1% | -4.3% | -6.6% | — |
| Jan 29, 2026 | BMO | — | 0.80 | — | 60.84 | -0.9% | +1.3% | +0.4% | +1.5% | +1.9% | +1.7% | — |
| Oct 23, 2025 | BMO | — | 0.82 | — | 61.02 | +0.8% | -0.9% | -1.0% | -2.9% | -4.1% | -6.6% | — |
| Jul 24, 2025 | BMO | — | 0.94 | — | 58.18 | +0.3% | -0.2% | +0.6% | -0.7% | -3.0% | -3.1% | — |
| Apr 29, 2025 | BMO | — | 0.92 | — | 52.21 | -1.4% | +0.6% | -0.9% | -0.0% | +0.9% | +0.2% | — |
| Mar 26, 2025 | BMO | — | 0.86 | — | 56.75 | +0.0% | -0.1% | -0.1% | -1.0% | -1.3% | -1.3% | — |
| Oct 29, 2024 | BMO | — | 1.02 | — | 64.24 | +0.8% | -0.1% | -0.3% | -1.3% | -0.2% | +0.6% | — |
| Jul 25, 2024 | BMO | — | 0.98 | — | 75.03 | -0.7% | -6.1% | -7.4% | -8.3% | -7.2% | -7.2% | — |
| Apr 25, 2024 | BMO | — | 1.09 | — | 67.16 | -1.4% | -1.3% | -1.8% | -1.3% | -1.4% | +1.1% | — |
| Mar 26, 2024 | BMO | — | 1.18 | — | 69.35 | +0.7% | -1.7% | +1.2% | +2.5% | +2.0% | +0.0% | — |
Recent Filings
8-K
Utah Medical Products, Inc. -- 8-K Filing
Unable to provide meaningful investor insight due to incomplete filing summary lacking specific business events, financial impacts, or material developments affecting Utah Medical Products.
May 4
8-K
Utah Medical Products Inc -- 8-K Filing
Utah Medical Products reported first-quarter 2026 financial results, indicating the company is meeting SEC disclosure requirements and maintaining operational updates for shareholder communication.
Apr 23
Data updated apr 27, 2026 7:11am
· Source: massive.com